BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28340031)

  • 1. One Year Clinical Correlates of EtG Positive Urine Screening in Alcohol-Dependent Patients: A Survival Analysis.
    Barrio P; Mondon S; Teixidor L; Ortega L; Vieta E; Gual A
    Alcohol Alcohol; 2017 Jul; 52(4):460-465. PubMed ID: 28340031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Ethyl Glucuronide Unraveling the Reality of Abstinence Monitoring in a Routine Outpatient Setting: A Cross-Sectional Comparison with Ethanol, Self Report and Clinical Judgment.
    Barrio P; Teixidor L; Rico N; Bruguera P; Ortega L; Bedini JL; Gual A
    Eur Addict Res; 2016; 22(5):243-8. PubMed ID: 27220985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients.
    Barrio P; Teixidor L; Ortega L; Lligoña A; Rico N; Bedini JL; Vieta E; Gual A
    Drug Alcohol Depend; 2018 Feb; 183():225-230. PubMed ID: 29291550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
    Dahl H; Hammarberg A; Franck J; Helander A
    Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethyl glucuronide (EtG): better than breathalyser or self-reports to detect covert short-term relapses into drinking.
    Wetterling T; Dibbelt L; Wetterling G; Göder R; Wurst F; Margraf M; Junghanns K
    Alcohol Alcohol; 2014; 49(1):51-4. PubMed ID: 24133131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Performance of Alcohol Markers Including Ethyl Glucuronide and Ethyl Sulphate to Detect Alcohol Use in Clients in a Community Alcohol Treatment Programme.
    Armer JM; Gunawardana L; Allcock RL
    Alcohol Alcohol; 2017 Jan; 52(1):29-34. PubMed ID: 27998921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary investigations on ethyl glucuronide and ethyl sulfate cutoffs for detecting alcohol consumption on the basis of an ingestion experiment and on data from withdrawal treatment.
    Albermann ME; Musshoff F; Doberentz E; Heese P; Banger M; Madea B
    Int J Legal Med; 2012 Sep; 126(5):757-64. PubMed ID: 22752748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethyl glucuronide: on the time course of excretion in urine during detoxification.
    Wurst FM; Seidl S; Ladewig D; Müller-Spahn F; Alt A
    Addict Biol; 2002 Oct; 7(4):427-34. PubMed ID: 14578020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence.
    Dahl H; Voltaire Carlsson A; Hillgren K; Helander A
    Alcohol Alcohol; 2011; 46(3):278-82. PubMed ID: 21339184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary ethyl glucuronide (EtG) and ethyl sulphate (EtS) assessment: valuable tools to improve verification of abstention in alcohol-dependent patients during in-patient treatment and at follow-ups.
    Junghanns K; Graf I; Pflüger J; Wetterling G; Ziems C; Ehrenthal D; Zöllner M; Dibbelt L; Backhaus J; Weinmann W; Wurst FM
    Addiction; 2009 Jun; 104(6):921-6. PubMed ID: 19466918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification.
    Helander A; Böttcher M; Fehr C; Dahmen N; Beck O
    Alcohol Alcohol; 2009; 44(1):55-61. PubMed ID: 18971292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness.
    McDonell MG; Leickly E; McPherson S; Skalisky J; Srebnik D; Angelo F; Vilardaga R; Nepom JR; Roll JM; Ries RK
    Am J Psychiatry; 2017 Apr; 174(4):370-377. PubMed ID: 28135843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption.
    Wurst FM; Dresen S; Allen JP; Wiesbeck G; Graf M; Weinmann W
    Addiction; 2006 Feb; 101(2):204-11. PubMed ID: 16445549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker.
    McDonell MG; Howell DN; McPherson S; Cameron JM; Srebnik D; Roll JM; Ries RK
    J Appl Behav Anal; 2012; 45(1):161-5. PubMed ID: 22403460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethyl glucuronide for detecting alcohol lapses in patients with an alcohol use disorder.
    Lahmek P; Michel L; Diviné C; Meunier N; Pham B; Cassereau C; Aussel C; Aubin HJ
    J Addict Med; 2012 Mar; 6(1):35-8. PubMed ID: 21817916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients.
    McDonell MG; Skalisky J; Leickly E; McPherson S; Battalio S; Nepom JR; Srebnik D; Roll J; Ries RK
    Drug Alcohol Depend; 2015 Dec; 157():184-7. PubMed ID: 26475403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethyl glucuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders.
    Skipper GE; Weinmann W; Thierauf A; Schaefer P; Wiesbeck G; Allen JP; Miller M; Wurst FM
    Alcohol Alcohol; 2004; 39(5):445-9. PubMed ID: 15289206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness.
    McDonell MG; Leickly E; McPherson S; Skalisky J; Hirchak K; Oluwoye O; Srebnik D; Roll JM; Ries RK
    Am J Addict; 2017 Oct; 26(7):673-675. PubMed ID: 28833832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethyl sulfate: a metabolite of ethanol in humans and a potential biomarker of acute alcohol intake.
    Helander A; Beck O
    J Anal Toxicol; 2005; 29(5):270-4. PubMed ID: 16105250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Ethyl-Glucuronide for Evaluation of Abstinence in Patients Presenting for Liver Transplantation.
    Alonso-Martín C; Tejedor-Tejada J; Valenzuela EF; Almohalla-Álvarez C; Sánchez-Martín F; Sanchez LFL; García-Pajares F; Sánchez-Antolín G
    Transplant Proc; 2020 Jun; 52(5):1450-1452. PubMed ID: 32434742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.